Detection of neuroblastoma cells in bone marrow using G(D2) specific monoclonal antibodies

N. K.V. Cheung, D. D. Von Hoff, S. E. Strandjord, P. F. Coccia

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Three murine monoclonal antibodies (Mab) against a cell surface antigen, the disialoganglioside G(D2), were investigated for detecting bone marrow metastasis in patients with neuroblastoma (NB) by indirect immunofluorescence (IF). As few as 0.01% NB cells could be detected. No Mab reactivity was found in 60 non-NB marrows. Thirty-five marrows from patients with stage III and stage IV NB at diagnosis were examined during the course of their disease. Tumor involvement was found in 74% by Mab, 55% by the two-layer soft agar clonogenic assay (CA), and 27% by conventional histochemical stains. All marrows containing NB histologically were positive for tumor by Mab; 71% were also positive by CA. Of histologically negative marrows, 63% were Mab positive, the majority (78%) of which were also positive by CA. All Mab nonreactive samples were negative histologically and by CA. We conclude that these antibodies are highly sensitive and specific in detecting NB metastasis in bone marrow.

Original languageEnglish (US)
Pages (from-to)363-369
Number of pages7
JournalJournal of Clinical Oncology
Volume4
Issue number3
DOIs
StatePublished - Jan 1 1986

Fingerprint

Neuroblastoma
Bone Marrow Cells
Bone Marrow
Monoclonal Antibodies
Neoplasm Metastasis
Neoplasm Antibodies
Surface Antigens
Indirect Fluorescent Antibody Technique
Agar
Coloring Agents
Antibodies
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Detection of neuroblastoma cells in bone marrow using G(D2) specific monoclonal antibodies. / Cheung, N. K.V.; Von Hoff, D. D.; Strandjord, S. E.; Coccia, P. F.

In: Journal of Clinical Oncology, Vol. 4, No. 3, 01.01.1986, p. 363-369.

Research output: Contribution to journalArticle

Cheung, N. K.V. ; Von Hoff, D. D. ; Strandjord, S. E. ; Coccia, P. F. / Detection of neuroblastoma cells in bone marrow using G(D2) specific monoclonal antibodies. In: Journal of Clinical Oncology. 1986 ; Vol. 4, No. 3. pp. 363-369.
@article{9118babf59a54603b74fbc2f9f266a47,
title = "Detection of neuroblastoma cells in bone marrow using G(D2) specific monoclonal antibodies",
abstract = "Three murine monoclonal antibodies (Mab) against a cell surface antigen, the disialoganglioside G(D2), were investigated for detecting bone marrow metastasis in patients with neuroblastoma (NB) by indirect immunofluorescence (IF). As few as 0.01{\%} NB cells could be detected. No Mab reactivity was found in 60 non-NB marrows. Thirty-five marrows from patients with stage III and stage IV NB at diagnosis were examined during the course of their disease. Tumor involvement was found in 74{\%} by Mab, 55{\%} by the two-layer soft agar clonogenic assay (CA), and 27{\%} by conventional histochemical stains. All marrows containing NB histologically were positive for tumor by Mab; 71{\%} were also positive by CA. Of histologically negative marrows, 63{\%} were Mab positive, the majority (78{\%}) of which were also positive by CA. All Mab nonreactive samples were negative histologically and by CA. We conclude that these antibodies are highly sensitive and specific in detecting NB metastasis in bone marrow.",
author = "Cheung, {N. K.V.} and {Von Hoff}, {D. D.} and Strandjord, {S. E.} and Coccia, {P. F.}",
year = "1986",
month = "1",
day = "1",
doi = "10.1200/JCO.1986.4.3.363",
language = "English (US)",
volume = "4",
pages = "363--369",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "3",

}

TY - JOUR

T1 - Detection of neuroblastoma cells in bone marrow using G(D2) specific monoclonal antibodies

AU - Cheung, N. K.V.

AU - Von Hoff, D. D.

AU - Strandjord, S. E.

AU - Coccia, P. F.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Three murine monoclonal antibodies (Mab) against a cell surface antigen, the disialoganglioside G(D2), were investigated for detecting bone marrow metastasis in patients with neuroblastoma (NB) by indirect immunofluorescence (IF). As few as 0.01% NB cells could be detected. No Mab reactivity was found in 60 non-NB marrows. Thirty-five marrows from patients with stage III and stage IV NB at diagnosis were examined during the course of their disease. Tumor involvement was found in 74% by Mab, 55% by the two-layer soft agar clonogenic assay (CA), and 27% by conventional histochemical stains. All marrows containing NB histologically were positive for tumor by Mab; 71% were also positive by CA. Of histologically negative marrows, 63% were Mab positive, the majority (78%) of which were also positive by CA. All Mab nonreactive samples were negative histologically and by CA. We conclude that these antibodies are highly sensitive and specific in detecting NB metastasis in bone marrow.

AB - Three murine monoclonal antibodies (Mab) against a cell surface antigen, the disialoganglioside G(D2), were investigated for detecting bone marrow metastasis in patients with neuroblastoma (NB) by indirect immunofluorescence (IF). As few as 0.01% NB cells could be detected. No Mab reactivity was found in 60 non-NB marrows. Thirty-five marrows from patients with stage III and stage IV NB at diagnosis were examined during the course of their disease. Tumor involvement was found in 74% by Mab, 55% by the two-layer soft agar clonogenic assay (CA), and 27% by conventional histochemical stains. All marrows containing NB histologically were positive for tumor by Mab; 71% were also positive by CA. Of histologically negative marrows, 63% were Mab positive, the majority (78%) of which were also positive by CA. All Mab nonreactive samples were negative histologically and by CA. We conclude that these antibodies are highly sensitive and specific in detecting NB metastasis in bone marrow.

UR - http://www.scopus.com/inward/record.url?scp=0022576063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022576063&partnerID=8YFLogxK

U2 - 10.1200/JCO.1986.4.3.363

DO - 10.1200/JCO.1986.4.3.363

M3 - Article

C2 - 3081691

AN - SCOPUS:0022576063

VL - 4

SP - 363

EP - 369

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 3

ER -